These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7264301)
21. Nano- and microparticles as adjuvants in vaccine design: success and failure is related to host natural antibodies. Sinyakov MS; Dror M; Lublin-Tennenbaum T; Salzberg S; Margel S; Avtalion RR Vaccine; 2006 Oct; 24(42-43):6534-41. PubMed ID: 16842893 [TBL] [Abstract][Full Text] [Related]
22. Influence of chemical surfactants on the biodegradation of crude oil by a mixed bacterial culture. Van Hamme JD; Ward OP Can J Microbiol; 1999 Feb; 45(2):130-7. PubMed ID: 10380646 [TBL] [Abstract][Full Text] [Related]
23. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations. Berner VK; Sura ME; Hunter KW Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470 [TBL] [Abstract][Full Text] [Related]
24. Emulsion stabilization by non-ionic surfactants: the relevance of surfactant cloud point. Florence AT; Madsen F; Puisieux F J Pharm Pharmacol; 1975 Jun; 27(6):385-94. PubMed ID: 237085 [TBL] [Abstract][Full Text] [Related]
25. The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces. Hunter RL; Bennett B Scand J Immunol; 1986 Mar; 23(3):287-300. PubMed ID: 3952469 [TBL] [Abstract][Full Text] [Related]
28. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity. Andrianov AK; Marin A; Roberts BE Biomacromolecules; 2005; 6(3):1375-9. PubMed ID: 15877355 [TBL] [Abstract][Full Text] [Related]
29. Prevention of topical and ocular oxidative stress by positively charged submicron emulsion. Benita S Biomed Pharmacother; 1999 May; 53(4):193-206. PubMed ID: 10392291 [TBL] [Abstract][Full Text] [Related]
30. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice. Song X; Bao S; Wu L; Hu S Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783 [TBL] [Abstract][Full Text] [Related]
31. Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjuvant. Snippe H; Johannesen L; Lizzio E; Merchant B Immunology; 1980 Mar; 39(3):399-405. PubMed ID: 7002767 [TBL] [Abstract][Full Text] [Related]
32. Antigen adjuvants. White RG Mod Trends Immunol; 1967; 2():28-52. PubMed ID: 4871640 [No Abstract] [Full Text] [Related]
33. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. Devani M; Ashford M; Craig DQ J Pharm Pharmacol; 2004 Mar; 56(3):307-16. PubMed ID: 15025855 [TBL] [Abstract][Full Text] [Related]
34. Effect of cationic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. Chidambaram N; Burgess DJ AAPS PharmSci; 2000; 2(3):E28. PubMed ID: 11741244 [TBL] [Abstract][Full Text] [Related]
35. Principles of emulsion stabilization with special reference to polymeric surfactants. Tadros T J Cosmet Sci; 2006; 57(2):153-69. PubMed ID: 16688378 [TBL] [Abstract][Full Text] [Related]
36. The nature of the apolar phase influences the structure of the protein emulsifier in oil-in-water emulsions stabilized by bovine serum albumin. A front-surface fluorescence study. Rampon V; Brossard C; Mouhous-Riou N; Bousseau B; Llamas G; Genot C Adv Colloid Interface Sci; 2004 May; 108-109():87-94. PubMed ID: 15072931 [TBL] [Abstract][Full Text] [Related]
38. Cationic polymers that enhance the performance of HbsAg DNA in vivo. Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694 [TBL] [Abstract][Full Text] [Related]
39. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone. Sek L; Boyd BJ; Charman WN; Porter CJ J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982 [TBL] [Abstract][Full Text] [Related]
40. Solubilization of pyrene by anionic-nonionic mixed surfactants. Zhou W; Zhu L J Hazard Mater; 2004 Jun; 109(1-3):213-20. PubMed ID: 15177761 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]